LCM
NUVB icon

LCM Capital Management’s Nuvation Bio NUVB Stock Holding History

LCM Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.3K Hold
15,000
– – 0.03% 106
2025
Q4 		$134K Sell
15,000
-500
-3% -$3.1K 0.07% 105
2025
Q3 		$57.4K Buy
15,500
+3,500
+29% +$9.54K 0.03% 105
2025
Q2 		$23.4K Buy
+12,000
New +$25K 0.01% 104

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LCM Capital Management's NUVB Position: Q1 2026 in Review

LCM Capital Management held its Nuvation Bio (NUVB) position steady in Q1 2026 at 15,000 shares worth $64.3K. The position accounts for 0.03% of the portfolio, ranked #106.

LCM Capital Management first reported a position in NUVB in Q2 2025 and has held it in 4 quarters since. The position peaked at $134K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • LCM Capital Management held 15,000 shares of Nuvation Bio worth $64.3K as of Q1 2026.
  • LCM Capital Management left its Nuvation Bio share count unchanged in Q1 2026.
  • Nuvation Bio made up 0.03% of LCM Capital Management's portfolio in Q1 2026, its #106 holding.
  • LCM Capital Management first reported a position in Nuvation Bio in Q2 2025 and has held it in 4 quarters since.
  • LCM Capital Management's Nuvation Bio position peaked at $134K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on LCM Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.